University, Subject, Country, Region, World

Johnson & Johnson Co. Scientists Rankings 2024

Country

Total 420 scientist, 1 country, 1 institution

List without CERN, Statistical Data etc.

Sort by last 6 years H Index

				AD Scientific Index - World Scientists Rankings - 2024				H INDEX			i10 INDEX			CITATION
University / Institution	Country	Region	World	Name	Country	University / Institution	Subject	Total	Last 6 year	Last 6 year/total	Total	Last 6 year	Last 6 year/total	Total	Last 6 year	Last 6 year/total
101	99,345	112,401	325,863	Weixuan Chen	United States	Johnson & Johnson Co.	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences Protiomics \| Post translational modification \| Drug discovery \|	24	19	0.792	32	25	0.781	2,113	1,341	0.635
102	100,103	113,235	329,409	Jamese Hilliard	United States	Johnson & Johnson Co.	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences	24	13	0.542	33	19	0.576	1,884	911	0.484
103	100,488	113,681	331,499	Philip S Murphy	United States	Johnson & Johnson Co.	J&J Clinical drug development \| imaging and digital measurements \|	24	13	0.542	29	13	0.448	1,743	563	0.323
104	100,946	114,192	334,069	Izabela Sokołowska	United States	Johnson & Johnson Co.		24	13	0.542	28	20	0.714	1,472	612	0.416
105	101,409	114,702	335,374	J Wadia	United States	Johnson & Johnson Co.	Janssen	23	17	0.739	36	23	0.639	5,912	1,344	0.227
106	101,776	115,096	336,137	Dirk Saerens	United States	Johnson & Johnson Co.	Medical and Health Sciences / Immunology Antibody Engineering \|	23	20	0.870	30	24	0.800	4,412	1,715	0.389
107	103,123	116,595	339,825	Charles Scales	United States	Johnson & Johnson Co.	Principal Scientist Johnson and Johnson	23	18	0.783	30	30	1.000	2,799	944	0.337
108	106,293	120,211	353,865	Oscar M Carrasco-Zevallos	United States	Johnson & Johnson Co.	Engineering & Technology / Computer Science Machine learning \| Image analysis \| Medical imaging \|	23	23	1.000	36	32	0.889	1,650	1,380	0.836
109	106,846	120,859	357,322	Minyan Li	United States	Johnson & Johnson Co.	Natural Sciences / Chemical Sciences Synthetic Organic Chemistry \| Catalyst \| Polymer Chemistry \| Material Science \|	23	21	0.913	34	34	1.000	1,379	1,089	0.790
110	106,977	121,008	358,178	Jeff Headd	United States	Johnson & Johnson Co.	Engineering & Technology / Computer Science Data Science \| Artificial Intelligence \| Patient Journey \| X-Ray Crystallography \|	22	18	0.818	26	23	0.885	45,877	26,770	0.584
			PREMIUM USER features: Education Information, Work Experience, Publications, Articles, Published Books, Book Chapters, Presentations, Courses, Projects, Editorial, Refereeing and Scientific Board, Patents/Designs, Academic Awards, Artistic Activities, Certificates/Courses/Trainings, Association and Community Memberships, and many other features.
111	107,444	121,507	359,069	Frank Niesen	United States	Johnson & Johnson Co.	Johnson & Johnson	22	12	0.545	25	17	0.680	5,223	2,011	0.385
112	107,474	121,540	359,137	Galeb Abu-Ali	United States	Johnson & Johnson Co.	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences Inflammatory Bowel Disease \| Celiac Disease \| Autoimmune Disease \|	22	20	0.909	25	23	0.920	5,052	4,297	0.851
113	107,626	121,708	359,504	Dariush Mohammadyani	United States	Johnson & Johnson Co.	Medical and Health Sciences / Biophysics Biophysics \| Molecular Modeling \| Data Science \| Mechanistic Modeling \|	22	19	0.864	22	21	0.955	4,486	3,522	0.785
114	107,644	121,726	359,545	Janet Nikolovski	United States	Johnson & Johnson Co.	Johnson and Johnson	22	14	0.636	26	18	0.692	4,429	1,883	0.425
115	107,873	121,981	360,123	Edward Siuda	United States	Johnson & Johnson Co.	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences neuroscience \|	22	19	0.864	24	21	0.875	3,861	2,405	0.623
116	110,470	124,872	368,263	Alan C Gibbs	United States	Johnson & Johnson Co.	Medical and Health Sciences / Biophysics Biophysics \| Chemistry \| Drug Discovery \|	22	13	0.591	28	18	0.643	2,082	651	0.313
117	111,327	125,855	371,897	Michael Moscherosch	United States	Johnson & Johnson Co.	Johnson & Johnson Sustainability \| Life Cycle Assessment \| Materials Development \|	22	9	0.409	36	9	0.250	1,846	375	0.203
118	112,925	127,670	379,811	John A Masucci	United States	Johnson & Johnson Co.	Natural Sciences / Chemical Sciences Analytical Chemistry \|	22	9	0.409	32	9	0.281	1,460	272	0.186
119	113,465	128,291	382,799	Ranjeet Dash	United States	Johnson & Johnson Co.	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences Pharmacokinetics \| Toxicokinetics \| Drug Metabolism \| Bioanalysis \|	22	21	0.955	36	32	0.889	1,235	1,088	0.881
120	113,836	128,701	384,064	Monica Jong	United States	Johnson & Johnson Co.		21	21	1.000	33	32	0.970	6,589	6,072	0.922
121	114,692	129,628	386,042	William L Perry III	United States	Johnson & Johnson Co.	columbia, university of TN, eli lilly, nci	21	11	0.524	23	13	0.565	3,299	504	0.153
122	114,701	129,637	386,069	Michael A Brady	United States	Johnson & Johnson Co.	Engineering & Technology / Metallurgical & Materials Engineering Materials Science \| Organic Electronics \| Additive Manufacturing \| Tissue Engineering \| Soft Matter \|	21	19	0.905	26	25	0.962	3,276	2,141	0.654
123	115,200	130,177	387,299	Xinyi Li	United States	Johnson & Johnson Co.	Researcher, Takeda Antibody discovery \| Immunology \| Neurodegenerative disease \| Protein homeostasis \|	21	16	0.762	22	20	0.909	2,805	1,352	0.482
124	115,487	130,501	388,116	Laurie S Conklin	United States	Johnson & Johnson Co.	Janssen inflammatory bowel diseases \| pediatric drug development \| Duchenne muscular dystrophy \|	21	19	0.905	31	28	0.903	2,585	1,575	0.609
125	116,543	131,692	391,669	Itzhack Goldberg	United States	Johnson & Johnson Co.	Ibm retiree patents \|	21	17	0.810	46	30	0.652	2,102	1,422	0.676
126	116,989	132,204	393,373	Jeffrey W Clymer	United States	Johnson & Johnson Co.	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences Pharmacology \| Pharmaceutics \| Surgical Medical Devices \| Genomics \| Statistics \|	21	17	0.810	37	24	0.649	1,963	1,425	0.726
127	117,747	133,064	396,405	Steven Xu	United States	Johnson & Johnson Co.	Janssen R&D drug development \| pharmacometrics \| bioinformatics \| machine learning \| and artificial intelligence \|	21	18	0.857	30	26	0.867	1,776	1,149	0.647
128	118,216	133,588	398,320	Neeraj Kohli	United States	Johnson & Johnson Co.	Medical and Health Sciences / Immunology Antibody engineering \| protein sciences \| bispecifics \| process development \|	21	13	0.619	27	16	0.593	1,681	722	0.430
129	119,724	135,293	406,049	Ryan J Murphy	United States	Johnson & Johnson Co.	Robotics and Digital Solutions, Johnson and Johnson Robotics \| Computer-Assisted Surgery \| Biomechanics \|	21	18	0.857	45	32	0.711	1,361	989	0.727
130	119,914	135,522	407,075	Derek Nankivil	United States	Johnson & Johnson Co.	Medical and Health Sciences / Ophthalmology Vision Science \| Biomedical Optics \| Biophotonics \| Ophthalmology \| Optics \|	21	17	0.810	27	23	0.852	1,315	752	0.572
131	120,900	136,615	411,452	Assieh Saadatpour	United States	Johnson & Johnson Co.	Natural Sciences / Molecular Biology & Genetics Computational Biology \| Immuno-oncology \| Biomarkers \| Single-cell genomics \| Network modeling \|	20	18	0.900	24	21	0.875	5,154	4,082	0.792
132	121,250	136,997	412,154	Börries Brandenburg	United States	Johnson & Johnson Co.	Janssen Vaccines (Johnson & Johnson) infectious diseases \| vaccines \| antibodies \| development \| clinical immunology \|	20	17	0.850	26	20	0.769	3,861	1,826	0.473
133	121,480	137,250	412,670	Anthony Rowe	United States	Johnson & Johnson Co.	Janssen R&D Systems Immunology \| Bioinformatics \| Machine learning \|	20	16	0.800	25	18	0.720	3,420	2,227	0.651
134	121,526	137,300	412,766	Ulrike Philippar	United States	Johnson & Johnson Co.	Senior Director Janssen R&D	20	18	0.900	26	25	0.962	3,354	1,283	0.383
135	121,687	137,480	413,125	Harmjan Kuipers	United States	Johnson & Johnson Co.	Medical and Health Sciences / Immunology immunology \| infectious diseases \| vaccines \|	20	15	0.750	25	17	0.680	3,149	928	0.295
136	122,083	137,908	414,066	Pedro Cruz	United States	Johnson & Johnson Co.	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences RWD \| Wearables \| Genomics \| Bioinformatics \| Healthcare \|	20	15	0.750	25	20	0.800	2,760	918	0.333
137	122,461	138,319	415,076	Jiejun Wu	United States	Johnson & Johnson Co.	Natural Sciences / Chemical Sciences analytical chemistry \|	20	14	0.700	29	16	0.552	2,505	1,117	0.446
138	122,619	138,491	415,543	James Weaver	United States	Johnson & Johnson Co.	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences Pharmacoepidemiology \|	20	17	0.850	28	24	0.857	2,408	1,575	0.654
139	123,223	139,165	417,564	Lohith Madireddy	United States	Johnson & Johnson Co.	Natural Sciences / Molecular Biology & Genetics Computational Biology \| Data Science \| Drug Discovery \| Genetics \| Pathways \|	20	18	0.900	26	25	0.962	2,105	1,668	0.792
140	123,648	139,640	418,998	Siva Krishna Mohan Nalluri	United States	Johnson & Johnson Co.	Engineering & Technology / Nanoscience and Nanotechnology Organic Materials \| Photochemistry \| Supramolecular Chemistry \| Stimuli-Responsive Materials \| Soft \|	20	17	0.850	21	17	0.810	1,961	1,404	0.716
141	123,841	139,855	419,638	Nádia Conceição-Neto	United States	Johnson & Johnson Co.	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences Viral metagenomics \| viral discovery \| biomarkers \| RNA viruses \| single-cell RNA-seq \|	20	19	0.950	26	24	0.923	1,906	1,723	0.904
142	124,529	140,641	422,347	Maté Ongenaert	United States	Johnson & Johnson Co.	Senior scientist computational biology at The Janssen Pharmaceutical Companies of … bioinformatics \| discovery \| biomarkers \| textmining \| sequencing \|	20	16	0.800	23	19	0.826	1,728	756	0.438
143	124,645	140,772	422,864	Liat Tsoref	United States	Johnson & Johnson Co.	Biosense Webster Medical Technology \| Cardiology \| Digital Health \| Israeli Hi-Tech Ecosystem \| Mobile Technology \|	20	14	0.700	26	19	0.731	1,700	765	0.450
144	124,946	141,114	424,123	Shiva Dibaj	United States	Johnson & Johnson Co.	Medical and Health Sciences / Biostatistics Biostatistics \| Cancer studies \| Statistical analysis \|	20	19	0.950	32	31	0.969	1,638	1,368	0.835
145	125,018	141,200	424,441	Kerem Bingol	United States	Johnson & Johnson Co.	Senior Scientist, Janssen Pharmaceutical Companies of Johnson & Johnson Structure Elucidation \| NMR \| LC-MS \| Drug Discovery \| Metabolomics \|	20	19	0.950	21	20	0.952	1,624	1,153	0.710
146	125,039	141,224	424,519	Stanley Belkowski	United States	Johnson & Johnson Co.	Medical and Health Sciences / Immunology Immunology \|	20	9	0.450	23	7	0.304	1,620	446	0.275
147	125,204	141,412	425,349	Jack Sheehan	United States	Johnson & Johnson Co.	Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences Diabetes \| CNS \|	20	17	0.850	34	26	0.765	1,583	1,027	0.649
148	125,532	141,775	426,721	Sanjoy Roy	United States	Johnson & Johnson Co.	Senior Director, Robotics & Digital Solutions HEMA Lead, Johnson & Johnson health outcomes research \| health economics \| health services research \| epidemiology \|	20	15	0.750	37	24	0.649	1,526	728	0.477
149	125,961	142,265	428,655	Gowtham Adamane Rao	United States	Johnson & Johnson Co.	Janssen Research & Development Comparative Effectiveness Research \| Medicine \| Epidemiology \| Bio-statistics \| pharmacoepidemiology \|	20	16	0.800	26	23	0.885	1,455	1,107	0.761
150	126,942	143,371	433,527	Laura Perez-Benito	United States	Johnson & Johnson Co.	Natural Sciences / Chemical Sciences GPCRs \| Molecular Dynamics \| FEP \| Oligomerization \| Bivalent ligands \|	20	20	1.000	25	24	0.960	1,288	1,216	0.944